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Death and Taxes:
Epidemiological and Economic Evidence on Smoking
Prabhat Jha
Toronto, CanadaDeath rates from smoking-attributable causes
have fallen sharply in high-income countries but
will rise globally unless today’s smokers, most of
whom live in low- and middle-income countries,
quit smoking before or during middle age. Tripling
taxes on tobacco could rapidly raise cessation rates
and deter smoking initiation.CURR EN T SMOK I NG PA T T E RN S
WOR LDW ID E
Over 1.1 billion adults over the age of 15 years
smoke worldwide [1,2]. Per-adult consumption of
cigarettes has more than halved in the last 3 decades
in the United States, the United Kingdom, Canada,
France, and other high-income countries [3]. In
contrast, male smoking has risen sharply in many
low- and middle-income countries such as China
and Indonesia. In India, smoking most commonly
occurs in the form of bidis, which are smaller than
cigarettes and typically contain only about one-
quarter as much tobacco [4].CONS EQUENC E S O F SMOK I NG
Tobacco use kills about 5–6 million people annually
worldwide, accounting for about 20% of all adult
male deaths and 5% of adult female deaths over
the age of 30 years [5–8]. Cardiovascular disease
is the leading cause of smoking-attributable deaths
worldwide and accounts for about 1.5 million
smoking deaths annually, of which 0.8 million
deaths are from acute heart attack [6,9]. Smoking
is a significant risk factor for both fatal and nonfatal
heart attack and stroke [10–12].From the Centre for Global Health Research, St. Michael’s Hospital
(prabhat.jha@utoronto.ca).On current smoking patterns, annual tobacco
deaths will rise to about 10 million by 2030, and
there will be about 1 billion tobacco deaths in the
21st century [5,13]. The full effects of smoking
have not yet been observed in low- and middle-in-
come countries, given the substantial delay of a few
decades between the peak effect of smoking and
deaths in middle age (defined as about 30–
69 years).
Provided due allowance is made for the long de-
lay between smoking onset and disease, reasonably
consistent quantitative estimates of risk emerge:
About 1 in 2 of all long-term smokers worldwide
are killed by their addiction [5,13]. A substantial
fraction of tobacco deaths worldwide occur in mid-
dle age: 50% in the United States and the United
Kingdom [14], 50% in China [15,16], and a sur-
prisingly high 70% in India [3]. The 10-year loss
of life among Indian male cigarette smokers is al-
ready about as extreme as that observed among
U.K. doctors who had started smoking early and
stayed as life-long smokers [17], despite the fact
that Indian smokers start later in life and smoke
fewer cigarettes per day than their Western coun-
terparts do.
At present, about 80% of worldwide smoking
deaths occur in men [6], but this is chiefly because
men who recently died also smoked more com-
monly and more intensively when they were young
than did the female smokers. The smoker/non-
smoker relative risks in U.S. women after 2002
are greater than they are in U.S. men [18].
Smoking cessation. Cessation by today’s smokers is
the only practicable way to avoid a substantial pro-
portion of tobacco deaths worldwide before 2050.
Ex-smoking prevalence is a good measure of, University of Toronto, Toronto, Canada. Correspondence: P. Jha
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J u l y 2 0 1 2 : 1 3 9 – 1 4 2cessation at a population level [2,5]. In the United
Kingdom, there are now twice as many ex-smokers
as smokers among those currently aged 50 years or
over [19]. Similar increases in cessation have been
reported in most high-income countries [20]. In
contrast, the prevalence of male ex-smokers in most
low- and middle-income countries remains well
below 10% [1,2]. Even these low figures may be
falsely elevated, because they include people who
quit because either they are too ill to continue or
because of the early symptoms of tobacco-attribut-
able illness, such as respiratory disease.
Widespread smoking cessation in high-income
countries has afforded researchers the opportunity
to study the impact of quitting at various ages on
the risk of death from tobacco-attributable diseases.
U.K. doctors who quit smoking before the onset of
major disease avoided most of the excess hazards of
smoking. In comparison to those who continued
smoking, the average gain in life expectancy for
those who quit smoking at 60, 50, 40, and 30 years
of age, was about 3, 6, 9, and nearly 10 years,
respectively [17]. Cessation before middle age pre-
vents more than 90% of the lung cancer mortality
attributable to smoking [19]. The absolute mortal-
ity reduction from cessation may be even greater for
other diseases, particularly vascular diseases, than
for lung cancer in the first decade or 2 after smok-
ing cessation.
Comparison of smoking and obesity risks. Studies
of tens of thousands of deaths have reliably assessed
mortality from adult obesity and from persistentA
Figure 1. Smoking and obesity risks, men aged 35–100 years. Note
smoking each shorten life expectancy by 10 years, and moderat
index ([BMI] if overweight) or a 10% prevalence of smoking shorten
BMI among men; affects among women are not greater [22]. (B) Ana
[17].smoking in developed countries [21]. In the Pro-
spective Studies Collaboration study [22] of
70,000 deaths in 900,000 adults, an increase of 2
units in the body-mass index ([BMI] the weight
in kilograms divided by the square of the height
in meters) among men who were overweight, re-
duced life span by 1 year (mostly from an increase
in vascular disease death rates). This 1-year loss
of life was comparable to the life span reduction
caused by a 10% increase in the prevalence of
smoking seen among U.K. doctors [17] (Fig. 1).
Moderate obesity (overweight, defined as BMI
range 30–35, mean: 32) shortens life expectancy
by approximately 3 years. Only among the small
minority of adults with severe obesity (BMI range
40–50, mean: 43) was the loss of life comparable
to the 10 years lost for being a life-long smoker.
Thus, smoking cessation (which is widely practica-
ble) can lead to a gain of about 10 years in life
expectancy; far more than smokers could expect
from weight control (which is currently far less
practicable).TAXA T I ON TO RA I S E TOBACCO
C E S SA T I ON RAT E S WOR LDW ID E
Higher taxation is the single most important inter-
vention to raise global smoking cessation rates. To-
bacco taxes and consumption are strongly inversely
related worldwide [23]. Studies from high-income
countries estimate that a 10% increase in cigaretteB
s: Male survival, ages 35–100 years: severe obesity and cigarette
e obesity shortens it by 3 years; so, 2 kg/m2 extra body mass
s it by 1 year. (A) Prospective Studies Collaboration analyses of
lyses of persistent cigarette smoking among male British doctors
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141prices will reduce overall smoking by 2.5–5.0% in
the medium term (within a few years) and perhaps
twice this in the longer term (5 years or longer)
[24]. The few studies from low- and middle-in-
come countries suggest an effect twice as great: a
10% increase in price will reduce smoking by 8%
in the medium term [24].
The United States and the United Kingdom
each took about 35 years and Canada about
25 years to halve per-adult cigarette consumption
(from about 10 per adult per day to about 5 [3]).
However, France took only 15 years to halve its
consumption [25]. France’s uptake of smoking
was chiefly after the Second World War and its
prevalence rose until the mid-1980s. From 1990
to 2005, cigarette consumption fell from about 6
cigarettes per adult per day to 3 cigarettes per day
(Fig. 2). This sharp decline was mostly due to a
sharp increase in tobacco taxation starting in
1990 under the then-President Jacques Chirac.
These price increases raised the inflation-adjusted
price by 3-fold. Among men, the corresponding
lung cancer rates at ages 35–44 years (which are
good indicators of recent exposure to smoking in
the population) fell sharply from 1997 onward.
During this period, revenues in real terms raised
from about 6 to 12 billion euros [25].
However, taxes are underused in most develop-
ing countries [7]. Taxes tend to be absolutely high-
er and account for a greater share of the retail price
(71% as of 2006) in high-income countries. In low-
and middle-income countries, taxes account forFigure 2. France: smoking, tax, and male lung cancer rates at you
cancer death rates, and relative price cigarettes are shown on the
are provided by Hill et al. [25]. The lung cancer death rates per 10
scale as smoking amount per day. Female lung cancer rates peaked
as of 2002.54% of the final price of cigarettes [26]. In South
Africa, tax as a percentage of retail price fell to
about 20% around 1990, but has subsequently risen
to nearly 40% [27]. Poland’s recent tax increases
have doubled the real price of cigarettes and re-
duced consumption. Mauritius and Mexico re-
cently raised taxes by about 30%, which has
already produced a drop in consumption [26].
A tax increase needed to raise the street prices of
a pack of 20 cigarettes by 70% would involve a 2-
to 2.8-fold increase across countries [5]. The in-
crease would raise the street price from about
US$0.7 to 1.3 in low-income countries, from about
US$1.3 to 2.3 in middle-income countries, and
from US$3.7 to 6.3 in high-income countries.
Such increases, though large, have been achieved
in numerous countries, including Canada, France,
Poland, and South Africa and within the various
states of the United States.
Nonprice interventions. A set of nonprice interven-
tions can substantially reduce tobacco consumption
[23,28]. Ideal programs are those that combine
price and nonprice interventions, including promi-
nent health information for smokers (including lo-
cal epidemiological evidence as well as use of
pictorial graphic warning labels on tobacco prod-
ucts), complete bans on tobacco advertising and
promotion, complete bans on smoking in public
places, and access to cessation therapies [28].
In sum, smoking-attributable death rates have
fallen sharply in high-income countries but will rise
globally unless today’s smokers, most of whom liveng ages, 1980–2010. The per capita cigarette consumption, lung
y-axes over time. Smoking per person per day and relative prices
0,000 are divided by 4, so as to enable these to be on the same
later than for the men, but those rates have also halted their rise
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before or during middle age. Tripling taxes on to-
bacco could rapidly raise cessation rates and deter
smoking initiation and could avoid several tens of
millions of premature deaths worldwide.ADD I T I ONA L MAT E R I A L
Additional information on tobacco hazards in India,
China, and developed countries (including updated
results to 2005 for the United Kingdom, the United
States, and Poland) are available at www.cghr.org/
tobacco and deathsfromsmoking. net.ACKNOWL EDGMENT S
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